Respirar

Respirar

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Respirar is an open-access journal published by Respirar in Argentina, publishing in PORTUGUESE and ENGLISH and SPANISH. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Respirar
ISSN
2953-3414
Country
Argentina
Languages
PORTUGUESE, ENGLISH, SPANISH
Access
Open access
Articles in DOAJ
26
Declared review time
20 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2023-11-10
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

26

Most recent article

3 years ago

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

183

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

2

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2023-11-10
Added to DOAJ
2023-11-10
Declared plagiarism screening
Declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
PKP PN
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
68%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Medicine (General)

LCC codes

R5-920

Subject areas

  • Medical research and treatments
  • Medical research and treatments
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Respiratory Support and Mechanisms
  • Respiratory Support and Mechanisms
  • Pleural and Pulmonary Diseases
Show all subjects (50)
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Asthma and respiratory diseases
  • Pleural and Pulmonary Diseases
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Lung Cancer Diagnosis and Treatment
  • Asthma and respiratory diseases
  • Delphi Technique in Research
  • Tracheal and airway disorders
  • Tracheal and airway disorders
  • Lung Cancer Diagnosis and Treatment
  • Health and Medical Education
  • Delphi Technique in Research
  • Health and Lifestyle Studies
  • Health and Lifestyle Studies
  • Nosocomial Infections in ICU
  • Nosocomial Infections in ICU
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Health and Medical Education
  • Medical Imaging and Pathology Studies
  • Obstructive Sleep Apnea Research
  • Public Health and Environmental Issues
  • Public Health and Environmental Issues
  • Lymphatic Disorders and Treatments
  • Respiratory viral infections research
  • Occupational and environmental lung diseases
  • Obstructive Sleep Apnea Research
  • Nursing care and research
  • Medical Imaging and Pathology Studies
  • Respiratory viral infections research
  • Ultrasound in Clinical Applications
  • Nursing care and research
  • Occupational and environmental lung diseases
  • Airway Management and Intubation Techniques
  • COVID-19 and healthcare impacts
  • Airway Management and Intubation Techniques
  • Lymphatic Disorders and Treatments
  • Ultrasound in Clinical Applications
  • Inhalation and Respiratory Drug Delivery
  • COVID-19 and healthcare impacts
  • Inhalation and Respiratory Drug Delivery

Keywords (DOAJ)

  • respiratory medicine
  • intensive care
  • sleep medicine
  • obstructive diseases
  • clinical pulmonology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: